最高の肝癌医師 - トップ107名の医師

ビュレント・カラゴズ教授は、ジョンズ・ホプキンス・メディシン提携施設であるアナドル医療センターにて、複雑な肝臓がん症例を専門としています。

• 医療腫瘍学における33年の経験の経験
• 分子標的療法およびがん免疫療法の専門家
• 腫瘍学に関する40件以上の研究論文を発表
• イスタンブール・オカン大学医学部教授
• トルコ医療腫瘍学会会員

タンルクル医師は、化学療法および腫瘍内科学による肝臓がんの治療を専門としています。彼女はがん治療の先進病院であるアナドル・メディカルセンターに勤務しています。

• 2017年より腫瘍内科専門医資格を取得
• トルコの非常に競争率の高い腫瘍内科専門医試験で第3位を獲得
• ハイダルパシャ・ニュムネ研修研究病院の腫瘍内科部門長を歴任
• 新たながん治療法に関する国際臨床試験に参加

ムスタファ・ソラク医師は、ハジェテペ大学がん研究所でフェローシップ研修を修了し、肝臓がんを含む消化器がんを専門としています。

• テキサス大学MDアンダーソンがんセンターにて専門研修を受講
• 乳がん、肺がん、消化器がんの複雑症例を担当
• イスタンブール・シシリ・エトファル研修研究病院にて研修を修了

Assoc. Prof. Gorkem Turkkan started his medical education at Gülhane Military Medical Academy in 2003 and completed it at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine in 2009. He completed his specialization at Trakya University Faculty of Medicine, Department of Radiation Oncology and became a radiation oncology specialist in 2016.

After completing his compulsory service, he served as a Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology, from May 2019 to February 2021. Meanwhile, between March and June 2020, he worked as a clinical researcher at Maastricht University Faculty of Medicine Department of Radiation Oncology – MAASTRO Clinic (Netherlands) on stereotactic radiotherapy, thoracic radiotherapy-related lung toxicity and proton therapy. While he was working at İstinye University Faculty of Medicine, Department of Radiation Oncology and Liv Hospital Ulus Radiation Oncology Clinic between March 2021 and April 2023, he received the title of Associate Professor in February 2023. She has been serving her patients at Hisar Hospital Intercontinental since May 2023.

He has performed both traditional radiotherapy and advanced radiotherapy throughout his career. He is one of the experienced physicians in our country in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which have become increasingly popular and used especially recently. So far, he has successfully completed more than 2500 radiotherapy sessions with the MR-Linac device.

He has been a member of the Turkish Society of Radiation Oncology (TROD) since 2013 and the European Society of Radiotherapy and Oncology (ESTRO) since 2015. He has 27 articles published in domestic and international journals, 31 oral-poster presentations presented at national and international congresses, and 5 book chapters published by national and international publishing houses. He taught Term I and Term V undergraduate courses at Muğla Sıtkı Koçman University Faculty of Medicine, postgraduate courses within the scope of Ear Nose and Throat Department Specialization training, and Radiotherapy associate degree courses at İstinye University Vocational School of Health Services. She is currently working on 2 ongoing TÜBİTAK Projects. He is married and has a son.

MEDICAL INTERESTS

MR-Linac

Linac

Stereotactic (Pinpoint) Radiotherapy

Prostate Cancers

Breast Cancers

Lung Cancers

Rectum Cancers

Brain and Spinal Cord Cancers

Head and Neck Cancers

Volumetric Arc Therapy (VMAT)

Intensity Modulated Radiotherapy (IMRT)

Kivanc Derya Peker医師は、Hisar Hospital Intercontinentalにて複雑な肝胆道系疾患を専門とし、200例以上の肝臓手術を執刀しています。

• メイヨークリニック（米国）にて肝膵胆道外科のフェローシップ研修を修了
• Bakırköy Dr. Sadi Konuk病院における肝膵胆道外科ユニットの創設者
• 膵臓癌および胃癌手術を400例以上執刀
• 肝臓癌、膵臓疾患、および複雑な胆道手術を専門とする

12,000件以上の腹腔鏡手術を執刀 – Ballesta医師は、Centro Médico Teknonにおける肝臓・膵臓がんに対する低侵襲技術のパイオニアです。

• 消化器外科における46年の経験年の臨床経験
• Dr. Ballesta腹腔鏡センター創設者兼医療ディレクター
• ダ・ヴィンチロボット支援手術を専門とする
• 代謝外科におけるIFSO認定卓越センター
• スペイン語および英語による国際診療を提供

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Pfaffenbach教授は、ゾーリンゲン腸腫瘍センターの所長として、年間9,000件以上の内視鏡的介入を実施しています。

• 消化器内科学および腫瘍学を専門とする34年の経験
• 消化器治療に関する130件以上の論文の著者
• 2008年よりゾーリンゲン大学附属病院消化器内科部長
• 欧州消化器内視鏡学会会員

パストラナ医師は、ガレニア病院において肝臓がんを専門とする外科腫瘍学の専門医資格を持つ医師であり、権威ある医療機関での豊富な研修経験を有しています。

• Centro Medico Nacional 20 de Noviembre Isssteにて研修修了
• Conacemによる専門医資格取得（2030年まで有効）
• メキシコ腫瘍学会（SMEO）会員
• 2020年よりアナワク大学にて教員として従事

ペレス・シャロン医師は、ソウラスキー医療センターにて化学療法や分子標的療法を含む肝臓がんの高度治療を専門としています。腫瘍学研究にも積極的に貢献し、根拠に基づいた患者ケアの実践に努めています。

• 肝臓がんに対する肝切除術および化学塞栓療法を実施
• 分子標的療法および免疫療法アプローチの専門家
• 臨床試験に対する患者の意識に関する研究を実施

メリムスキー教授はスーラスキー医療センターの肉腫ユニットを率い、41年の経験の経験を持つ肝臓癌治療の深い専門知識を有しています。

• 軟部組織および骨腫瘍学の専門医
• 肉腫に関するESMOファカルティのメンバー
• テルアビブ大学腫瘍学科元主任
• 腫瘍免疫学における広範な研究実績

Prof. Nadir Arber is a top gastroenterologist from Israel with over 30 years of experience in the field. He is specialized in the prevention, early diagnostics, and treatment of GI cancers, with education from Hebrew University, Tel Aviv University, and NewYork-Presbyterian Center. He has written over 300 papers on his research and is a member of numerous organizations in the field.

Education and Specialization

• Faculty of Medicine, Hacettepe University
• 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
• Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
• Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
• Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

Work Experience

• 2009 - Kayseri Training and Research Hospital, Hospital
• Acıbadem Kayseri
• 2017 - 2018 - Lara Private Anadolu Hospital
• 2018 - Medical Park Antalya Hospital Complex

Expertise

• Diagnosis of organ tumors
• Chemotherapy in cancer treatment
• Targeted cancer therapies
• Immunotherapy in cancer treatment
• Next-generation genetic research in cancer treatment
• Complementary medicine in cancer treatment
• Medical oncology

Dr. Asawadech Sanbua

Medical Radiation​ Oncologist

• Passed palliative care training at the Karunrak Center. Khon Kaen University
  
   
• Certificate of oncotherm
  
   
• Expert in treating cancer with oncothermia machines (or hyperthermia machine) 5 years experience.
  
   
• 14 years of experience working in radiotherapy. Able to plan treatment (Planning 2D, 3D, IMRT, VMAT)
  
   
• Can provide chemical treatment, Chemotherapy, targeted drugs therapy) Immunotherapy (Immunotherapy) 

Dr. Jaroslav Tvaruzek is a specialist in robotic surgery. Dr. Tvaruzek is a leading certified expert by Intuitive Surgical - the American produced of the original Da Vinci robots. The doctor is a member of Association of Aesthetic Medicine and Association of Bariatric Surgery.

Dr. Tvaruzek heads the Center of Robotic Surgery located in the St. Zdislava Hospital (the Czech Republic). The doctor has performed over 3,500 robotic surgeries for his practice. Among them are:

• prostatectomy with preservation of the erectile function
• transoral surgeries (removal tumors of the nasopharynx, larynx, trachea, mouth)
• thyroidectomy
• nephrectomy
• bariatric surgeries (surgical treatment of obesity).

Head of Teaching at the Puerto Vallarta Regional Hospital

2020-2023

Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020

General practitioner in private medical office

2015-2022

Doctor in charge of weight control clinic

2013-2014

Medical assistant in dermatology clinic

2008-2013

Medical Assistant in Dermatological procedures.

 Medical Assistant in minimally invasive surgical procedures

 Operation of fractional laser machine - IPIXEL-ER and

facial rejuvenation with IPL.

 Experience in laser hair removal with Intense Pulsed Light and

radiofrequency

 Experience with ultrasonic cavitation

 Experience with ultraviolet (UV) light phototherapy machine for the

treatment of psoriasis and vitiligo.

 Experience assisting in Botox and Fillers procedures.

 Biomagnet certified by the Higher Institute of Biomagnetism

doctor ISAAC GOIZ DURAN

 Experience in clinical records

 Training in continuing education and professional development of teachers

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations